JP2019511558A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019511558A5 JP2019511558A5 JP2018554479A JP2018554479A JP2019511558A5 JP 2019511558 A5 JP2019511558 A5 JP 2019511558A5 JP 2018554479 A JP2018554479 A JP 2018554479A JP 2018554479 A JP2018554479 A JP 2018554479A JP 2019511558 A5 JP2019511558 A5 JP 2019511558A5
- Authority
- JP
- Japan
- Prior art keywords
- patch
- excipients
- patches according
- abaroparachido
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021069599A JP6919087B2 (ja) | 2016-04-18 | 2021-04-16 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
| JP2021121353A JP7139498B2 (ja) | 2016-04-18 | 2021-07-26 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
| JP2022142197A JP2022171769A (ja) | 2016-04-18 | 2022-09-07 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662324336P | 2016-04-18 | 2016-04-18 | |
| US62/324,336 | 2016-04-18 | ||
| US201662353249P | 2016-06-22 | 2016-06-22 | |
| US62/353,249 | 2016-06-22 | ||
| US201662396196P | 2016-09-18 | 2016-09-18 | |
| US62/396,196 | 2016-09-18 | ||
| PCT/US2016/056196 WO2017062922A1 (en) | 2015-10-09 | 2016-10-08 | Formulations of pthrp analogues, transdermal patches thereof, and uses thereof |
| USPCT/US2016/056196 | 2016-10-08 | ||
| US201762479250P | 2017-03-30 | 2017-03-30 | |
| US62/479,250 | 2017-03-30 | ||
| PCT/US2017/026462 WO2017184355A1 (en) | 2016-04-18 | 2017-04-06 | Formulations of abaloparatide, transdermal patches thereof, and uses thereof |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021069599A Division JP6919087B2 (ja) | 2016-04-18 | 2021-04-16 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
| JP2021121353A Division JP7139498B2 (ja) | 2016-04-18 | 2021-07-26 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019511558A JP2019511558A (ja) | 2019-04-25 |
| JP2019511558A5 true JP2019511558A5 (enExample) | 2020-02-13 |
| JP6920341B2 JP6920341B2 (ja) | 2021-08-18 |
Family
ID=60116311
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554479A Expired - Fee Related JP6920341B2 (ja) | 2016-04-18 | 2017-04-06 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
| JP2021069599A Expired - Fee Related JP6919087B2 (ja) | 2016-04-18 | 2021-04-16 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
| JP2021121353A Expired - Fee Related JP7139498B2 (ja) | 2016-04-18 | 2021-07-26 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
| JP2022142197A Pending JP2022171769A (ja) | 2016-04-18 | 2022-09-07 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021069599A Expired - Fee Related JP6919087B2 (ja) | 2016-04-18 | 2021-04-16 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
| JP2021121353A Expired - Fee Related JP7139498B2 (ja) | 2016-04-18 | 2021-07-26 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
| JP2022142197A Pending JP2022171769A (ja) | 2016-04-18 | 2022-09-07 | アバロパラチドの製剤、その経皮パッチ、およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10568937B2 (enExample) |
| EP (2) | EP3481414B1 (enExample) |
| JP (4) | JP6920341B2 (enExample) |
| AU (2) | AU2017253674B2 (enExample) |
| CA (1) | CA3020333A1 (enExample) |
| ES (1) | ES2904891T3 (enExample) |
| WO (1) | WO2017184355A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2904891T3 (es) | 2016-04-18 | 2022-04-06 | Radius Health Inc | Formulaciones de abaloparatida, parche transdérmico de la misma y usos de la misma |
| US10996208B2 (en) | 2017-04-28 | 2021-05-04 | Radius Health, Inc. | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
| EP3930743A1 (en) * | 2019-02-28 | 2022-01-05 | Radius Health, Inc. | Transdermal system for the delivery of abaloparatide and method of use |
| CN110917243B (zh) * | 2019-12-30 | 2021-06-04 | 南京晓庄学院 | 一种含植物提取物的凝胶膏剂及其制备方法 |
| WO2021149012A1 (en) | 2020-01-24 | 2021-07-29 | Radius Health, Inc. | Methods of stimulating bone growth with abalopartide and denosumab |
| JP2024502334A (ja) * | 2021-01-05 | 2024-01-18 | ラジウス ヘルス，インコーポレイテッド | アバロパラチドを用いた長骨骨折の治療 |
| US12029562B2 (en) | 2021-04-14 | 2024-07-09 | Satio, Inc. | Dermal patch system |
| US11877848B2 (en) | 2021-11-08 | 2024-01-23 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12053284B2 (en) | 2021-11-08 | 2024-08-06 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12023156B2 (en) | 2021-10-13 | 2024-07-02 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12048543B2 (en) | 2021-11-08 | 2024-07-30 | Satio, Inc. | Dermal patch for collecting a physiological sample with removable vial |
| US12178979B2 (en) | 2021-10-13 | 2024-12-31 | Satio, Inc. | Dermal patch for delivering a pharmaceutical |
| US11964121B2 (en) | 2021-10-13 | 2024-04-23 | Satio, Inc. | Mono dose dermal patch for pharmaceutical delivery |
| US12214346B2 (en) | 2021-10-13 | 2025-02-04 | Satio, Inc. | Dermal patch with a diagnostic test strip |
| WO2023281447A1 (en) | 2021-07-07 | 2023-01-12 | Radius Health, Inc. | Methods of treating a cardiovascular ischemic event |
| WO2024246840A1 (en) * | 2023-06-01 | 2024-12-05 | Radius Health, Inc. | Methods for identification and quantitation of abaloparatide and related peptide impurities |
| CN119113134B (zh) * | 2024-09-13 | 2025-05-16 | 南京羚诺生物医药技术研究院有限公司 | 一种提升阿巴帕肽半衰期的制备方法及其在治疗骨质疏松症中的用途 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5589452A (en) * | 1992-07-14 | 1996-12-31 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| BR9812068A (pt) | 1997-09-09 | 2000-09-26 | Hoffmann La Roche | Processo para a cicatrização óssea e restauração de fraturas e utilização de um análogo de polipeptìdeo de peptìdeo (pthrp) relacionado com hormÈnios de paratireóide e seus sais |
| US20040033950A1 (en) | 2000-09-26 | 2004-02-19 | Hock Janet M. | Method of increasing bone toughness and stiffness and reducing fractures |
| GB0017999D0 (en) | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
| CA2427381A1 (en) | 2000-10-26 | 2002-11-28 | Alza Corporation | Transdermal drug delivery devices having coated microprotrusions |
| NZ529029A (en) | 2001-04-20 | 2005-07-29 | Alza Corp | Microprojection array having a beneficial agent containing coating |
| US6881203B2 (en) | 2001-09-05 | 2005-04-19 | 3M Innovative Properties Company | Microneedle arrays and methods of manufacturing the same |
| US20050009739A1 (en) * | 2002-02-14 | 2005-01-13 | Wei Wang | Formulation strategies in stabilizing peptides in organic solvents and in dried states |
| AU2003239869A1 (en) * | 2002-05-23 | 2003-12-12 | Michael Holick | Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy |
| WO2004009172A1 (en) | 2002-07-19 | 2004-01-29 | 3M Innovative Properties Company | Microneedle devices and microneedle delivery apparatus |
| CA2530531A1 (en) | 2003-06-30 | 2005-01-20 | Alza Corporation | Formulations for coated microprojections containing non-volatile counterions |
| WO2005014034A1 (en) * | 2003-07-14 | 2005-02-17 | Nps Allelix Corp. | Stabilized formulation of parathyroid hormone |
| CA2536249A1 (en) | 2003-08-25 | 2005-03-10 | 3M Innovative Properties Company | Delivery of immune response modifier compounds |
| MXPA06013168A (es) | 2004-05-13 | 2007-05-15 | Johnson & Johnson | Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea. |
| WO2006055844A2 (en) | 2004-11-18 | 2006-05-26 | 3M Innovative Properties Company | Method of contact coating a microneedle array |
| US20070270341A1 (en) | 2005-09-06 | 2007-11-22 | Paul Morley | Parathyroid hormone analogues and methods of use |
| JP2009522288A (ja) | 2005-12-28 | 2009-06-11 | アルザ コーポレイション | 安定な治療剤形 |
| WO2007106597A2 (en) * | 2006-03-15 | 2007-09-20 | Alza Corporation | Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia |
| US7803770B2 (en) | 2006-10-03 | 2010-09-28 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
| DK2073789T3 (da) | 2006-10-03 | 2019-08-05 | Radius Health Inc | Stabil sammensætning omfattende et knogle-anabolisk protein, nemlig en pthrp-analog, og anvendelser deraf |
| US20090016935A1 (en) * | 2007-07-09 | 2009-01-15 | Andrianov Alexander K | Coating formulations including polyphosphazene polyelectrolytes and biologically active agents and asperities coated with such formulations |
| US20110051041A1 (en) * | 2008-05-16 | 2011-03-03 | Yuji Yashiro | Backlight unit and liquid crystal display device |
| KR20160150109A (ko) | 2008-11-18 | 2016-12-28 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 중공 마이크로니들 어레이 |
| JP2012523270A (ja) | 2009-04-10 | 2012-10-04 | スリーエム イノベイティブ プロパティズ カンパニー | 中空マイクロニードルアレイを製造する方法並びにそれに由来する製品及びその使用法 |
| JP5856071B2 (ja) | 2009-12-18 | 2016-02-09 | スリーエム イノベイティブ プロパティズ カンパニー | サーモトロピック液晶ポリマーの成形及びそこから作製される物品 |
| SG183421A1 (en) | 2010-02-24 | 2012-09-27 | Hisamitsu Pharmaceutical Co | Micro-needle device and preparation method |
| US8637458B2 (en) | 2010-05-12 | 2014-01-28 | Biodel Inc. | Insulin with a stable basal release profile |
| EP2680871A4 (en) | 2011-03-01 | 2015-04-22 | Sloan Kettering Inst Cancer | SYMBOLS HORMONE ANALOGUE, COMPOSITIONS THEREOF AND USES THEREOF |
| KR20140047043A (ko) * | 2011-04-22 | 2014-04-21 | 라디우스 헬쓰, 인코포레이티드 | PTH, PTHrP를 위한 약물 전달 방법 및 관련 펩티드 |
| AU2012345777B2 (en) | 2011-11-30 | 2016-05-12 | Kindeva Drug Delivery L.P. | Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same |
| US9581438B2 (en) | 2012-12-31 | 2017-02-28 | General Electric Company | Systems and methods for control of a non-destructive testing system |
| ES2692722T3 (es) | 2013-02-13 | 2018-12-04 | Hisamitsu Pharmaceutical Co., Inc. | Composición de recubrimiento de microagujas y dispositivo de microagujas |
| WO2015040697A1 (ja) | 2013-09-18 | 2015-03-26 | コスメディ製薬株式会社 | マイクロニードルパッチ適用装置及びパッチホルダー |
| DK3006045T3 (en) * | 2014-10-07 | 2017-07-17 | Cyprumed Gmbh | Pharmaceutical formulations for oral administration of peptide or protein drugs |
| EP4137147A3 (en) | 2015-03-03 | 2023-04-05 | Radius Health, Inc. | Uses of abaloparatide in reducing fracture risk |
| EP3359181A1 (en) | 2015-10-07 | 2018-08-15 | Cyprumed GmbH | Pharmaceutical formulations for the oral delivery of peptide drugs |
| DK3359129T3 (da) | 2015-10-09 | 2022-05-09 | Kindeva Drug Delivery Lp | Zinksammensætninger til belagte mikronåleanordninger |
| HRP20211127T1 (hr) | 2015-10-09 | 2021-10-15 | Radius Health, Inc. | Formulacije analoga pthrp, njihovi transdermalni flasteri, i njihova uporaba |
| ES2904891T3 (es) | 2016-04-18 | 2022-04-06 | Radius Health Inc | Formulaciones de abaloparatida, parche transdérmico de la misma y usos de la misma |
-
2017
- 2017-04-06 ES ES17786338T patent/ES2904891T3/es active Active
- 2017-04-06 JP JP2018554479A patent/JP6920341B2/ja not_active Expired - Fee Related
- 2017-04-06 EP EP17786338.8A patent/EP3481414B1/en not_active Not-in-force
- 2017-04-06 CA CA3020333A patent/CA3020333A1/en active Pending
- 2017-04-06 US US16/092,587 patent/US10568937B2/en active Active
- 2017-04-06 EP EP21203373.2A patent/EP3998061A1/en not_active Withdrawn
- 2017-04-06 AU AU2017253674A patent/AU2017253674B2/en not_active Ceased
- 2017-04-06 WO PCT/US2017/026462 patent/WO2017184355A1/en not_active Ceased
-
2020
- 2020-01-03 US US16/733,779 patent/US10980862B2/en not_active Expired - Fee Related
-
2021
- 2021-03-23 US US17/209,777 patent/US20210369816A1/en not_active Abandoned
- 2021-04-16 JP JP2021069599A patent/JP6919087B2/ja not_active Expired - Fee Related
- 2021-06-23 AU AU2021204233A patent/AU2021204233B2/en not_active Ceased
- 2021-07-26 JP JP2021121353A patent/JP7139498B2/ja not_active Expired - Fee Related
-
2022
- 2022-09-07 JP JP2022142197A patent/JP2022171769A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY187047A (en) | Selective pyy compounds and uses thereof | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| CY1119007T1 (el) | Συνθεσεις και μεθοδοι αγωγης πνευμονικης υπερτασης | |
| CY1123627T1 (el) | Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου | |
| MX383665B (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
| WO2015009991A3 (en) | Methods, systems, and compositions for promoting bone growth | |
| PH12019502150A1 (en) | Compounds and methods for the treatment of parasitic diseases | |
| JOP20200315B1 (ar) | مركبات بورينون واستخدامها في معالجة السرطان | |
| TN2017000467A1 (en) | Amido-substituted cyclohexane derivatives | |
| CY1118947T1 (el) | Ασυμμετρες ουριες και ιατρικες χρησεις αυτων | |
| HRP20211127T1 (hr) | Formulacije analoga pthrp, njihovi transdermalni flasteri, i njihova uporaba | |
| MX2016012574A (es) | Compuestos heteroarilo sustituidos y metodos de uso. | |
| WO2017037594A3 (zh) | 用于减少局部脂肪的医药组成物及其用途 | |
| EA201691490A1 (ru) | Фармацевтическая композиция, содержащая бринзоламид | |
| MX2020012336A (es) | Formulacion farmaceutica. | |
| PH12015501945B1 (en) | Formulations of organic compounds | |
| EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
| WO2016140933A3 (en) | Immediate release soluble ibuprofen compositions | |
| EA201790383A1 (ru) | Композиции и способы лечения и профилактики инфекций области хирургического вмешательства | |
| JOP20190086A1 (ar) | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب | |
| WO2015081319A3 (en) | Activity enhancing curcumin compositions and methods of use | |
| ES2948324R1 (es) | Proceso para preparar (15alfa,16alfa,17beta)-estra-1,3,5(10)-trieno-3,15,16,17-tetrol monohidrato (Estetrol monohidrato) | |
| WO2016004413A3 (en) | Gls1 inhibitors for treating disease | |
| UA118474C2 (uk) | (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| CY1125075T1 (el) | Εκχυλισμα salvia haenkei σαν δραστικος παραγοντας στις διαδικασιες επανεπιθηλιωσης και επουλωσης ιστων |